Fasting Health Benefits: Evolutionary Mismatch & Modern Science

Fasting’s Evolutionary Mismatch and Modern Potential

The human body evolved to function and thrive for long periods without food. Scientists from the University of Pittsburgh and University of California, San Francisco propose that controlled, intermittent activation of these ancient fasting pathways could be a powerful tool to improve metabolic health and promote healthier aging, though conclusive proof in humans remains elusive.

ADIOL: A Long-Forgotten Hormone Powers Fasting’s Benefits

Groundbreaking work from Kaveh Ashrafi’s lab at UC San Francisco provides a new mechanistic link between fasting and health. Published in Aging Cell, their research identifies the steroid hormone 5-androstene-3β,17β-diol (ADIOL) as a central player. Discovered in humans a century ago, ADIOL’s function remained a mystery. Using the nematode C. elegans, the team found that both fasting and caloric restriction trigger transcriptional programs that boost ADIOL production.

This hormone then activates a receptor called NHR-91, a homolog of the human estrogen receptor β. The activated NHR-91 pathway suppresses the production of kynurenic acid, a metabolite derived from the amino acid tryptophan. Elevated kynurenic acid has been implicated in neurological and age-related disorders. The study demonstrates that reducing this metabolite is a primary way fasting improves measures of healthspan, such as motility and stress resistance. Crucially, ADIOL enhanced health without extending lifespan, indicating these are separable biological outcomes.

Human Evidence Remains in the Cautious Phase

While the worm research reveals a clear pathway, translating this to human longevity advice requires caution. In their perspective published in Biogerontology, researchers Matthew Steinhauser and Pouneh Fazeli from the University of Pittsburgh assess the human evidence base. They confirm the evolutionary rationale: humans possess “adaptive mechanisms that enable survival even with zero calories for periods of months or longer.” Intermittent, “low-dose” exposure to this metabolic stress might activate beneficial pathways.

However, they state clearly that benefits for longevity “have not been proven in humans.” Their analysis concludes that for motivated individuals who are overweight or obese, and who lack specific risk factors, a trial of intermittent fasting or time-restricted eating to improve metabolic health is reasonable. The risk factors they list are critical: frailty, osteoporosis or osteopenia, or a history of eating disorders. For these groups, fasting could be harmful. The authors argue the evidence is currently “not sufficient to justify widespread adoption of fasting practices,” but also insufficient to dismiss its potential.

From Intermittent Practice to Future Pharmacology

The research points toward two distinct but complementary futures for fasting science. The first involves optimizing dietary protocols. Steinhauser and Fazeli call for human studies that incorporate detailed “mechanistic and multi-omics endpoints” to finally understand how fasting works in people. This could identify biomarkers to personalize fasting schedules for maximum benefit with minimal risk.

The second, and perhaps more profound, future lies in pharmacology. The identification of the ADIOL-NHR-91-kynurenic acid axis provides a specific target. The ultimate aim, as noted by the Pittsburgh team, is to develop a “fasting mimetic drug” that can activate these protective pathways without requiring long-term adherence to what can be an “onerous dietary restriction.” This mirrors the scientific journey of compounds like NMN, which aims to replicate the benefits of exercise and calorie restriction on cellular energy metabolism.

How to Approach Fasting for Health Today

Given the current state of evidence, a pragmatic approach is warranted. For generally healthy individuals interested in metabolic improvement, evidence-supported protocols like 16:8 time-restricted eating or periodic 24-hour fasts may offer benefits related to insulin sensitivity and weight management, as seen in studies on autophagy and mitochondrial health. These practices should be approached as experiments in self-observation, not guaranteed longevity fixes.

Monitoring energy, mood, and physical performance is essential. It is also vital to prioritize nutrient-dense foods during eating windows. For those seeking the theorized benefits without fasting, supporting related cellular processes may be an alternative. This includes ensuring adequate intake of precursors for NAD+ synthesis or considering compounds like spermidine to support autophagy.

The discovery of the ADIOL pathway is a significant step in moving from observational phenomenology to mechanistic understanding. It provides a concrete biological story for how a period without food sends a signal that recalibrates cellular metabolism toward resilience. While we await the large, long-term human trials needed for definitive answers, this research refines our understanding of fasting from a simple act of omission into a targeted biological trigger.

Sources:
https://pubmed.ncbi.nlm.nih.gov/42043665/
https://pubmed.ncbi.nlm.nih.gov/42021510/
https://pubmed.ncbi.nlm.nih.gov/41889977/